Bennett M. Celsa

Array ( [id] => 4088308 [patent_doc_number] => 06025472 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'N-substituted glycine derivatives as enzyme inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/484509 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 29128 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025472.pdf [firstpage_image] =>[orig_patent_app_number] => 484509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3925571 [patent_doc_number] => 05952298 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Cryptophycins' [patent_app_type] => 1 [patent_app_number] => 8/482141 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 41228 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952298.pdf [firstpage_image] =>[orig_patent_app_number] => 482141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4287979 [patent_doc_number] => 06211154 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Ketoheterocyclic inhibitors of factor Xa' [patent_app_type] => 1 [patent_app_number] => 8/480491 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13762 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211154.pdf [firstpage_image] =>[orig_patent_app_number] => 480491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933421 [patent_doc_number] => 05939392 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Method of thrombin inhibition' [patent_app_type] => 1 [patent_app_number] => 8/481811 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67494 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939392.pdf [firstpage_image] =>[orig_patent_app_number] => 481811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3737811 [patent_doc_number] => 05698669 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Tri-arginine insulins' [patent_app_type] => 1 [patent_app_number] => 8/466945 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5356 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698669.pdf [firstpage_image] =>[orig_patent_app_number] => 466945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4209692 [patent_doc_number] => 06028168 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Lanthionine bridged peptides' [patent_app_type] => 1 [patent_app_number] => 8/467472 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16554 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028168.pdf [firstpage_image] =>[orig_patent_app_number] => 467472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3763574 [patent_doc_number] => 05844076 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Totally synthetic affinity reagents' [patent_app_type] => 1 [patent_app_number] => 8/471939 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 26 [patent_no_of_words] => 42289 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/844/05844076.pdf [firstpage_image] =>[orig_patent_app_number] => 471939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3815298 [patent_doc_number] => 05710249 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'Amino acids and processes for making peptides using same' [patent_app_type] => 1 [patent_app_number] => 8/465854 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18133 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/710/05710249.pdf [firstpage_image] =>[orig_patent_app_number] => 465854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771783 [patent_doc_number] => 05734011 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'Ligand precursors for incorporation into peptides' [patent_app_type] => 1 [patent_app_number] => 8/469028 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2341 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/734/05734011.pdf [firstpage_image] =>[orig_patent_app_number] => 469028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3628297 [patent_doc_number] => 05686421 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Hydantoin derivates' [patent_app_type] => 1 [patent_app_number] => 8/467526 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8692 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 541 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686421.pdf [firstpage_image] =>[orig_patent_app_number] => 467526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4059750 [patent_doc_number] => 05864011 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'Cancer related antigen' [patent_app_type] => 1 [patent_app_number] => 8/469009 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 45 [patent_no_of_words] => 21146 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/864/05864011.pdf [firstpage_image] =>[orig_patent_app_number] => 469009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3774954 [patent_doc_number] => 05817624 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Permeation enhancer compositions for increased absorption of therapeutic proteins through the colonic membrane' [patent_app_type] => 1 [patent_app_number] => 8/465661 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2196 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817624.pdf [firstpage_image] =>[orig_patent_app_number] => 465661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3650140 [patent_doc_number] => 05684130 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Process for synthesis of organic compounds using magnetic particles' [patent_app_type] => 1 [patent_app_number] => 8/462201 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7393 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/684/05684130.pdf [firstpage_image] =>[orig_patent_app_number] => 462201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3837812 [patent_doc_number] => 05846941 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Isosteric antiherpes peptide derivatives II' [patent_app_type] => 1 [patent_app_number] => 8/460957 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21462 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846941.pdf [firstpage_image] =>[orig_patent_app_number] => 460957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4035942 [patent_doc_number] => 05856306 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Inhibitors of trypsin-like enzymes' [patent_app_type] => 1 [patent_app_number] => 8/459177 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6234 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856306.pdf [firstpage_image] =>[orig_patent_app_number] => 459177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4002698 [patent_doc_number] => 05858979 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Inhibitors and substrates of thrombin' [patent_app_type] => 1 [patent_app_number] => 8/459394 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11628 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 440 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858979.pdf [firstpage_image] =>[orig_patent_app_number] => 459394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1357594 [patent_doc_number] => 06573078 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Compounds which inhibit HIV replication' [patent_app_type] => B1 [patent_app_number] => 08/464003 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 7240 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573078.pdf [firstpage_image] =>[orig_patent_app_number] => 08464003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3839628 [patent_doc_number] => 05744445 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'Method of treating pulmonary disease states with non-naturally occuring amphipathic peptides' [patent_app_type] => 1 [patent_app_number] => 8/457798 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8360 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744445.pdf [firstpage_image] =>[orig_patent_app_number] => 457798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3871272 [patent_doc_number] => 05763396 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Method of treating or preventing type 1 diabetes by oral administration of insulin' [patent_app_type] => 1 [patent_app_number] => 8/456953 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5250 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763396.pdf [firstpage_image] =>[orig_patent_app_number] => 456953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3789538 [patent_doc_number] => 05840837 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Analogs of parathyroid hormone and parathyroid hormone relate peptide synthesis and use for the treatment of osteoporosis' [patent_app_type] => 1 [patent_app_number] => 8/449447 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23303 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840837.pdf [firstpage_image] =>[orig_patent_app_number] => 449447 [rel_patent_id] =>[rel_patent_doc_number] =>)